Biora Therapeutics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Two
Biora Therapeutics, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Two of $864.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo · last filed 2021-05-13
- 2021-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $864.00K.
- 2020-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $864.00K.
- 2020-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Two $864.00K.
- 2020-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Two $891.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Two |
|---|---|
| 2021-03-31 | $864.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $864.00K 10-K · filed 2021-03-18 |
| 2020-09-30 | $864.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $891.00K 10-Q · filed 2020-08-14 |